Free Trial

Xylem Inc. $XYL Shares Purchased by Focus Partners Wealth

Xylem logo with Business Services background

Key Points

  • Focus Partners Wealth increased its stake in Xylem Inc. by 217.4% in Q1, owning 59,608 shares valued at over $7 million.
  • Xylem's stock has a consensus rating of "Moderate Buy" with a price target of $150.75, reflecting positive analyst sentiment.
  • The company reported $1.26 EPS for the last quarter, exceeding expectations, and declared a quarterly dividend of $0.40 per share.
  • Five stocks we like better than Xylem.

Focus Partners Wealth raised its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 217.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,608 shares of the industrial products company's stock after buying an additional 40,827 shares during the period. Focus Partners Wealth's holdings in Xylem were worth $7,121,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of XYL. Vanguard Group Inc. boosted its position in Xylem by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock worth $3,465,122,000 after purchasing an additional 362,127 shares during the period. Royal Bank of Canada boosted its position in shares of Xylem by 7.9% in the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after buying an additional 320,500 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Xylem by 7.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company's stock valued at $480,767,000 after buying an additional 274,123 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock valued at $435,119,000 after buying an additional 301,070 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after acquiring an additional 3,239,203 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on XYL shares. TD Cowen upped their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research report on Tuesday, August 26th. Citigroup reaffirmed a "buy" rating and set a $152.00 target price (up from $137.00) on shares of Xylem in a research report on Monday, July 14th. Mizuho boosted their price target on Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research note on Friday. Cowen restated a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Finally, JPMorgan Chase & Co. began coverage on Xylem in a report on Friday, May 30th. They set an "overweight" rating and a $148.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $150.75.

Read Our Latest Report on XYL

Xylem Stock Down 0.2%

Shares of Xylem stock opened at $141.55 on Friday. The stock has a market capitalization of $34.45 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 2.45 and a beta of 1.09. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The business's 50 day simple moving average is $138.19 and its 200-day simple moving average is $127.61.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter last year, the business earned $1.09 earnings per share. Xylem's revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be given a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's payout ratio is 41.56%.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company's stock.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.